Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer
763 employees · est. 2014 · London, United Kingdom
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development.
11 employees · est. 2006 · Calabasas, United States
ImmunoCellular Therapeutics Ltd is the older company (2014 vs 2006); Autolus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Autolus Therapeutics | ImmunoCellular Therapeutics Ltd |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2006 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Calabasas, United States |
| Employees | ||
| Employees | 763 larger | 11 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Grant |
| Total Funding | ||
| Total Funding | $1.07B | $32.47M |
| Funding Rounds | ||
| Funding Rounds | 10 | 4 |
| Services | ||
| Services | Development of autologous T cell therapies, Advanced cell programming, Manufacturing of T cells, Clinical trial management, Pipeline products for cancer and autoimmune diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with cancer and autoimmune diseases, Healthcare professionals, Investors interested in biotech innovations, Research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | CAR T Cell Therapy, T Cell Programming, Cancer Treatment, Autologous T Cell Therapies, Next-generation Therapies, Obe-cel (obecabtagene Autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7, AUTO8, Autoimmune Disease Treatment, Biopharmaceuticals, Therapeutic Pipeline | ImmunoCellular Therapeutics, Immune-based Therapies, Immunotherapy Development, Cancer Treatment, Clinical-stage, ICT-107, Dendritic Cell Immunotherapy, Glioblastoma Multiforme, Brain Cancer, Immune System Stimulation, Tumor Antigens, Immune Response, Cancer Immunotherapy, Patient-specific Treatment |
| Website | ||
| Website | autolus.com | imuc.com |
About Autolus Therapeutics
Autolus Therapeutics, founded in 2014, is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries. Based in the United Kingdom, the company is renowned for its innovative approach towards cancer treatment, with a clear focus on developing precisely targeted and highly con...
About ImmunoCellular Therapeutics Ltd
ImmunoCellular Therapeutics is a biotechnology firm pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development. Founded in 2006, the company focuses on creating immune-based treatments for cancers. Its flagship product, ICT-107, is a de...
We will tell you when either one moves
BounceWatch watches Autolus Therapeutics and ImmunoCellular Therapeutics Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Autolus Therapeutics and ImmunoCellular Therape... — by email.
Frequently Asked Questions
Compare Autolus Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Autolus Therapeutics on 1 Apr 2026, and ImmunoCellular Therapeutics Ltd on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.